Current concepts of treatment for left ventricular thrombus: A sys-tematic meta-analysis comparing direct oral anticoagulants versus vitamin K-antagonists

Back

ESC Professional Premium Access

Current concepts of treatment for left ventricular thrombus: A sys-tematic meta-analysis comparing direct oral anticoagulants versus vitamin K-antagonists

Session: Pharmacotherapy in acute coronary syndromes

Topic: Postinfarction Period

Speaker: Doctor T. Seiler (Lucerne, CH)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Thomas Seiler

Kantonsspital Lucerne, Lucerne (Switzerland)

0 follower

4 more presentations in this session

State-of-the-art lecture on pharmacotherapy for acute coronary syndromes

Speaker: Professor G. Montalescot (Paris, FR)

Access

Slides

Video

Incidence and pattern of repeat coronary revascularizations in patients with acute coronary syndromes treated with ticagrelor or prasugrel

Speaker: Doctor A. Aytekin (Munich, DE)

SGLT-2 inhibitors are associated with lower rates of mortality following myocardial infarction in patients with type 2 diabetes - A SWEDEHEART observational study

Speaker: Doctor H. Rosen (Lund, SE)

Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry

Speaker: Mr A. Haakansson (Lund, SE)

Access the full session

Pharmacotherapy in acute coronary syndromes

Speakers: Doctor T. Seiler, Professor G. Montalescot, Doctor A. Aytekin, Doctor H. Rosen, Mr A. Haakansson

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Current concepts of treatment for left ventricular thrombus: A sys-tematic meta-analysis comparing direct oral anticoagulants versus vitamin K-antagonists

About the speaker

Doctor Thomas Seiler

4 more presentations in this session

State-of-the-art lecture on pharmacotherapy for acute coronary syndromes

Incidence and pattern of repeat coronary revascularizations in patients with acute coronary syndromes treated with ticagrelor or prasugrel

SGLT-2 inhibitors are associated with lower rates of mortality following myocardial infarction in patients with type 2 diabetes - A SWEDEHEART observational study

Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry

Access the full session

Pharmacotherapy in acute coronary syndromes

About the event

ESC Congress 2023

ESC 365 is supported by